These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1792471)

  • 61. Scaling down.
    Seeman MV
    Am J Psychiatry; 2003 May; 160(5):847-9. PubMed ID: 12727685
    [No Abstract]   [Full Text] [Related]  

  • 62. Remission of rheumatoid arthritis and other disorders of immunity in patients taking monoamine oxidase inhibitors.
    Lieb J
    Int J Immunopharmacol; 1983; 5(4):353-7. PubMed ID: 6629596
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Reactions on 'The effectiveness of monoamine oxidase inhibitors in treatment-resistant depressive disorders in clinical practice; a retrospective open-label study'].
    Schulte PFJ; Nolen WA
    Tijdschr Psychiatr; 2020; 62(6):502-505. PubMed ID: 32583871
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Selective amine oxidase inhibitors: basic to clinical studies and back.
    Murphy DL; Sunderland T; Garrick NA; Aulakh CS; Cohen RM
    Psychopharmacol Ser; 1987; 3():135-46. PubMed ID: 3547393
    [No Abstract]   [Full Text] [Related]  

  • 65. Monoamine oxidase inhibitors.
    Elliot-Baker S
    Med J Aust; 1987 Sep; 147(6):315. PubMed ID: 3626959
    [No Abstract]   [Full Text] [Related]  

  • 66. [New selective monoamine oxidase inhibitors in the treatment of depressive disorders].
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():1-50. PubMed ID: 2587672
    [No Abstract]   [Full Text] [Related]  

  • 67. [Monoamine oxidase inhibitors].
    Raphael M
    Soins Psychiatr; 1987 Nov; (85):I-II. PubMed ID: 3433146
    [No Abstract]   [Full Text] [Related]  

  • 68. Discussion on the monoamine oxidase inhibitors.
    Schiele BC
    Psychopharmacol Bull; 1986; 22(1):16-8. PubMed ID: 3726062
    [No Abstract]   [Full Text] [Related]  

  • 69. [Therapeutic indications of monoamine oxidase inhibitors].
    Cervera Enguix S
    Rev Med Univ Navarra; 1991; 36(2):35-7. PubMed ID: 1792471
    [No Abstract]   [Full Text] [Related]  

  • 70. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An overview of monoamine oxidase inhibitors. Introductory remarks.
    Burrows D
    J Neural Transm Suppl; 1989; 28():1-3. PubMed ID: 2677239
    [No Abstract]   [Full Text] [Related]  

  • 72. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of the cardiac-impaired depressed patient. Part I: General considerations, heterocyclic antidepressants, and monoamine oxidase inhibitors.
    Goldstein MG; Guttmacher LB
    Psychiatr Med; 1988; 6(3):1-33. PubMed ID: 3062672
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.